---
title: "Tandem Diabetes Care, Inc. (TNDM.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TNDM.US.md"
symbol: "TNDM.US"
name: "Tandem Diabetes Care, Inc."
industry: "Health Care Equipment"
datetime: "2026-05-20T07:12:41.726Z"
locales:
  - [en](https://longbridge.com/en/quote/TNDM.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TNDM.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TNDM.US.md)
---

# Tandem Diabetes Care, Inc. (TNDM.US)

## Company Overview

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It’s flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user’s body.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [www.tandemdiabetes.com](https://www.tandemdiabetes.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:16.000Z

**Overall: C (0.58)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 66 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 4.54% |  |
| Net Profit YoY | 48.58% |  |
| P/B Ratio | 7.17 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 949813173.54 |  |
| Revenue | 1027535000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -65.73% | E |
| Profit Margin | -9.20% | D |
| Gross Margin | 55.33% | B |
| Revenue YoY | 4.54% | C |
| Net Profit YoY | 48.58% | B |
| Total Assets YoY | 25.08% | A |
| Net Assets YoY | -14.74% | E |
| Cash Flow Margin | -20.74% | D |
| OCF YoY | 4.54% | C |
| Turnover | 0.99 | A |
| Gearing Ratio | 88.52% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Tandem Diabetes Care, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "4.54%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "48.58%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "7.17",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "949813173.54",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "1027535000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-65.73%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-9.20%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "55.33%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "4.54%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "48.58%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "25.08%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "-14.74%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-20.74%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "4.54%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "0.99",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "88.52%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -10.05 | 144/183 | - | - | - |
| PB | 7.17 | 115/183 | 10.46 | 8.68 | 6.71 |
| PS (TTM) | 0.92 | 28/183 | 1.44 | 1.29 | 0.97 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | C | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-19T04:00:00.000Z

Total Analysts: **24**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 9 | 38% |
| Overweight | 4 | 17% |
| Hold | 11 | 46% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 13.86 |
| Highest Target | 56.00 |
| Lowest Target | 20.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/TNDM.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/TNDM.US/norm.md)
- [Related News](https://longbridge.com/en/quote/TNDM.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/TNDM.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**